ArticleBritish journal of haematology2022

Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics.

Eleonora Calabretta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.